Olema Pharmaceuticals Inc (NASDAQ: OLMA) kicked off on Tuesday, down -5.00% from the previous trading day, before settling in for the closing price of $27.98. Over the past 52 weeks, OLMA has traded in a range of $2.86-$29.51.
A company in the Healthcare sector has dropped its sales by -83.00% annually for the last half of the decade. While this was happening, its average annual earnings per share was recorded 11.16%. With a float of $63.67 million, this company’s outstanding shares have now reached $68.65 million.
In an organization with 96 employees, it is important to assess its efficiency.
Olema Pharmaceuticals Inc (OLMA) Insider and Institutional Ownership
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Olema Pharmaceuticals Inc is 19.06%, while institutional ownership is 75.11%. The most recent insider transaction that took place on Sep 18 ’25, was worth 83,300. In this transaction Director of this company sold 10,000 shares at a rate of $8.33, taking the stock ownership to the 744,140 shares. Before that another transaction happened on Sep 16 ’25, when Company’s Director sold 10,000 for $8.04, making the entire transaction worth $80,400. This insider now owns 754,140 shares in total.
Olema Pharmaceuticals Inc (OLMA) Latest Financial update
In the latest quarterly report, which was put into the public domain on 12/31/2024, the organization reported -0.51 earnings per share (EPS), lower than consensus estimate (set at 0.17) by -0.68. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.56 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 11.16% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -2.30% during the next five years compared to -83.00% drop over the previous five years of trading.
Olema Pharmaceuticals Inc (NASDAQ: OLMA) Trading Performance Indicators
Take a look at Olema Pharmaceuticals Inc’s (OLMA) current performance indicators. Last quarter, stock had a quick ratio of 8.03.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.81, a number that is poised to hit -0.54 in the next quarter and is forecasted to reach -2.33 in one year’s time.
Technical Analysis of Olema Pharmaceuticals Inc (OLMA)
Let’s dig in a bit further. During the last 5-days, its volume was 2.52 million. That was better than the volume of 1.57 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 53.11%.
During the past 100 days, Olema Pharmaceuticals Inc’s (OLMA) raw stochastic average was set at 88.33%, which indicates a significant increase from 71.66% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 2.54 in the past 14 days, which was higher than the 0.94 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $14.13, while its 200-day Moving Average is $7.33. However, in the short run, Olema Pharmaceuticals Inc’s stock first resistance to watch stands at $27.94. Second resistance stands at $29.30. The third major resistance level sits at $30.46. If the price goes on to break the first support level at $25.42, it is likely to go to the next support level at $24.26. The third support level lies at $22.90 if the price breaches the second support level.
Olema Pharmaceuticals Inc (NASDAQ: OLMA) Key Stats
The company with the Market Capitalisation of 2.09 billion has total of 68,660K Shares Outstanding. Its annual sales at the moment are 0 K in contrast with the sum of -129,470 K annual income. Company’s last quarter sales were recorded 0 K and last quarter income was -42,220 K.
